Poseida Therapeutics, Inc. Common Stock

Go to Poseida Therapeutics, Inc. Common Stock Website

$2.32

(%)
Live
Previous Close

$2.32

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$205.5 million USD

Day Vol.

Previous Day Vol.

Currency

USD

Primary Exchange

Nasdaq

Poseida Therapeutics Inc is a clinical-stage biopharmaceutical company focused on leveraging non-viral gene engineering technologies to create life-saving therapeutics for patients with a high unmet medical need. It has built a pipeline of autologous...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Adaptimmune's (ADAP) shares plummet as the company;s collaboration to develop and commercialize allogeneic cell therapies with Roche gets terminated.

Related tickers: GSK, RHHBY, PSTX, ADAP.

Read Full Article

Poseida is expected to release results from the phase 1 study using P-BCMA-ALLO1 on April 8th, 2024. Read why PSTX stock is a Buy.

Related tickers: PSTX.

Read Full Article
Trending Tickers
DATS

XNAS

$1.25
(%)
LASE

XNAS

$2.05
(%)
NYCB

XNYS

$2.79
(%)
PACW

XNAS

$7.54
(%)
MLGO

XNAS

$0.00
(%)